Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Arkema SA and CJ Cheiljedang Corp Announce Launch of the Start of the Construction of Their Bio-Methionine and Thiochemicals Complex in Malaysia


Monday, 8 Oct 2012 05:24am EDT 

Arkema SA and CJ Cheiljedang Corp announced the official launch of the start of the construction of a Bio-Methionine plant and Thiochemicals Platform in Kerteh, in the State of Terengganu in Malaysia. Arkema owns an in-house production process of Methyl Mercaptan, a sulfur-based intermediate that is used in the production of Methionine. CJ owns an industrial bio-fermentation process to produce L-Methionine, a bio-amino acid for animal feed, from renewable raw materials. Total investment amount for the joint project is about USD 450 million, where CJ will build and operate Bio-Methionine plant and Arkema will build and operate Thiochemical plant. Upon completion, Arkema will supply a key raw ingredient to CJ for the production of Bio-Methionine. When completed, the facility will be able to produce 80,000 metric tons of Bio-Methionine additives for poultry and 50,000 metric tons of sulphur derivatives for the petrochemical markets. 

Company Quote

55.59
-2.23 -3.86%
19 Sep 2014